Here is the news release on the deal
HEALTHWORLD'S SUBSIDIARY HEADCOUNT SIGNS FIRST U.S. CONTRACT
7/10/98 8:45
Business Editors
NEW YORK--(BUSINESS WIRE)--July 10, 1998--Healthworld Corporation
(NASDAQ: HWLD) today announced that its U.S. contract sales
organization subsidiary, Headcount, LLC, has signed an agreement with
ZymeTx, Inc. (NASDAQ: ZMTX), to market the newly launched ZstatFlu(tm)
product to the U.S. marketplace.
Steven Girgenti, Chairman and Chief Executive Officer of
Healthworld Corporation, commented, "We are excited to be working with
ZymeTx, Inc. on the marketing of ZstatFlu(tm). This is an important
new product, and currently the only rapid point-of-care test to
diagnose influenza." Mr. Girgenti added, "This 30 sales rep contract
is a significant step for Headcount, LLC, in establishing its contract
sales business in the rapidly growing U.S. marketplace."
Mark Abbonizio, President of Headcount, LLC, commented, "We are
delighted to be working with ZymeTX, Inc., a young company with a very
bright future. ZstatFlu(tm) is a strong product offering with the
potential to change the way physicians manage influenza."
Headcount management has successfully developed specialty selling
programs for Fortune 500 pharmaceutical, diagnostic, device and
healthcare manufacturers. Healthworld is a leading international
marketing and communications services company specializing in
healthcare.
This press release contains statements which constitute
forward-looking statements within the meaning of Section 27 A of the
Securities Act of 1933, as amended, and Section 21E of the Securities
Exchange Act of 1934, as amended. Those statements include statements
regarding the intent, belief or current expectations of the Company
and its management team. Prospective investors are cautioned that any
such forward-looking statements are not guarantees of future
performance and involve risks and uncertainties, and that actual
results may differ materially from those projected in the
forward-looking statements. Such risks and uncertainties include,
among other things, competitive, economic and regulatory factors in
the health care marketing and communications industry and the
pharmaceutical and health care industry, general economic conditions
and other risks and uncertainties that may be detailed, from
time-to-time, in Healthworld's reports filed with the Securities and
Exchange Commission.
--30--db/ny*
CONTACT: Healthworld Corporation, New York
Steven Girgenti
Chief Executive Officer
212/625-4216
or
Stuart Diamond
Chief Financial Officer
212/625-4249
KEYWORD: NEW YORK
INDUSTRY KEYWORD: MEDICINE PHARMACEUTICAL
Today's News On The Net - Business Wire's full file on the Internet
with Hyperlinks to your home page.
URL: businesswire.com
|
